sar425899 sanofi glp-1 glucagon dual agonist Current GLP-1, GIP, and receptor co-agonists in development Frontiers | Striking the Balance:

Should a GLP-1 (Glucagon-like peptide-1) receptor agonist, such as semaglutide (generic name) or tirzepatide (generic name), be continued or discontinued in a patient who has achieved a BMI reduction from 30 to 22?

CNS actions GLP-1R signaling plays a critical role in the maintenance of glucose homeostasis as deletion of the GLP-1R in mice results in impaired glucose tolerance (Scrocchi et al., 1996) and physiological levels of GLP-1 enhance meal-related insulin secretion in humans (Kreymann et al., 1987

It can also raise your resting metabolism

Although not thought to be directly influenced by obesity, lipoprotein (a) is an independent risk factor for cardiovascular disease that is determined by genetics

While numerous other GLP1 receptor agonists have since been developed for the management of diabetes, it wasnt until 2014 that a GLP1 receptor agonist, Saxenda (liraglutide), was approved for obesity (liraglutide had previously been approved for diabetes under the name Victoza)

Plasma was collected after centrifugation (3000 g , 10 min at 4 C) and stored at 80 C until assay